Potential binding sites containing nine residues derived from binding site similarity searches
DrReposER ID
Hit
Organism / Macromolecule
Interface
HETATM
RMSD
Dali Z-score
Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
LYS A 42GLY A 65ALA A 67GLU A 88SER A 90ASP A 113ALA A 114ASP A 133GLN A 136
SAM A 301 (-3.0A)SAM A 301 ( 3.8A)SAM A 301 (-3.1A)SAM A 301 (-2.4A)SAM A 301 ( 4.9A)SAM A 301 (-3.6A)SAM A 301 (-3.4A)SAM A 301 (-3.7A)SAM A 301 (-3.4A)
0.67A
3nmuA-1nt2A:0.23nmuF-1nt2A:21.3
3nmuA-1nt2A:21.393nmuF-1nt2A:42.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
LYS E 57GLY E 81GLU E 105PHE E 106SER E 107ASP E 130ALA E 131ASP E 150GLN E 153
C X 5 ( 2.7A)NoneNoneNone G A 22 ( 2.7A)NoneNone C X 5 ( 3.2A) G A 24 ( 3.0A)
1.03A
3nmuA-4by9E:undetectable3nmuF-4by9E:34.7
3nmuA-4by9E:22.513nmuF-4by9E:97.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
LYS E 60GLY E 84ALA E 86GLU E 108SER E 110ASP E 133ALA E 134ASP E 153GLN E 156
U I 4 ( 3.9A)SAH E 301 (-3.8A)SAH E 301 ( 3.7A)SAH E 301 (-3.0A) A G 24 ( 2.5A)SAH E 301 (-3.5A)SAH E 301 (-3.6A)SAH E 301 (-3.7A)SAH E 301 (-3.8A)
0.69A
3nmuA-5ginE:undetectable3nmuF-5ginE:36.5
3nmuA-5ginE:22.513nmuF-5ginE:50.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.